Log In
BCIQ
Print this Print this
 

myT Primer BRAF assay

  Manage Alerts
Collapse Summary General Information
Company Swift Biosciences Inc.
DescriptionAssay using myT Primer qPCR technology to detect BRAF mutations
Molecular Target BRAF
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsDetect BRAF mutations
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today